Smith & Nephew
SNN
$29.77
Share price
-0.57%
Change (1 day)
9.61%
Change (1 year)
Categories
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company.
Smith & Nephew (SNN) - Cash on Hand
Cash on Hand as of December 2024 : $0.61 Billion USD
According to Smith & Nephew
's latest financial reports the company has $0.61 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Smith & Nephew - Cash on Hand chart (from 1999 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $0.61 B | 104.97% |
| 2023-12-31 | $0.30 B | -13.71% |
| 2022-12-31 | $0.35 B | -72.87% |
| 2021-12-31 | $1.29 B | -26.79% |
| 2020-12-31 | $1.76 B | 536.1% |
| 2019-12-31 | $0.27 B | -24.11% |
| 2018-12-31 | $0.36 B | 115.98% |
| 2017-12-31 | $0.16 B | 69% |
| 2016-12-31 | $0.10 B | -16.67% |
| 2015-12-31 | $0.12 B | 29.03% |
| 2014-12-31 | $93 M | -32.12% |
| 2013-12-31 | $0.13 B | -23.03% |
| 2012-12-31 | $0.17 B | -3.26% |
| 2011-12-31 | $0.18 B | -11.11% |
| 2010-12-31 | $0.20 B | 7.81% |
| 2009-12-31 | $0.19 B | 32.41% |
| 2008-12-31 | $0.14 B | -14.71% |
| 2007-12-31 | $0.17 B | -50.87% |
| 2006-12-31 | $0.34 B | 129.14% |
| 2005-12-31 | $0.15 B | 357.58% |
| 2004-12-31 | $33 M | 26.92% |
| 2003-12-31 | $26 M | -28.29% |
| 2002-12-31 | $36.25 M | -17% |
| 2001-12-31 | $43.68 M | 18.77% |
| 2000-12-31 | $36.78 M | -77.35% |
| 1999-12-31 | $0.16 B | 96.12% |
| 1998-12-31 | $82.8 M | -12.28% |
| 1997-12-31 | $94.39 M | -31.53% |
| 1996-12-31 | $0.13 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $38.78 B | 6,165.11% | 🇺🇸 USA |
 Stryker Corporation SYK | $2.40 B | 289.18% | 🇺🇸 USA |
 Edwards Lifesciences EW | $3.89 B | 529.81% | 🇺🇸 USA |
 Boston Scientific BSX | $0.72 B | 17.12% | 🇺🇸 USA |
 Orthofix Medical
OFIX | $57.95 M | -90.64% | 🇺🇸 USA |
 CONMED CNMD | $35.48 M | -94.27% | 🇺🇸 USA |